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pituitary–adrenal (HPA) axis response to subsequent acute
stressors with adaptation of the response to a homotypic and
sensitization of the response to a heterotypic stressor. Since
vasopressin (AVP) activity has been reported to change during
chronic stress, we investigated whether this was an important
factor in HPA facilitation. We therefore tested whether
vasopressin 1b receptor (AVPR1B) blockade altered the
ACTH and corticosterone response to heterotypic stressors
followingCR stress. Adultmale ratswere exposed toCR, single
restraint, or were left undisturbed in the home cage. Twenty-
four hours after the last restraint, rats were injected with either aJournal of Endocrinology (2009) 200, 285–291
0022–0795/09/0200–285 q 2009 Society for Endocrinology Printed in GreatAVPR1B antagonist (Org, 30 mg/kg, s.c.) or vehicle (5%
mulgofen in saline, 0.2/kg, s.c.) and then exposed to either
restraint, lipopolysaccharide (LPS) or white noise. CR resulted
in the adaptation of the ACTH and corticosterone response to
restraint and this effect was not prevented by pretreatment with
Org. Although we found no effect of CR on LPS-induced
ACTH and corticosterone secretion, both repeated and single
episodes of restraint induced the sensitization of the ACTH,
but not corticosterone response to acute noise. Pretreatment
with Org reduced the exaggerated ACTH response to noise
after both single and repeated exposure to restraint.
Journal of Endocrinology (2009) 200, 285–291Introduction
Vasopressin (AVP) and corticotropin-releasing hormone
(CRH) are the two main neuropeptides regulating the
hypothalamic–pituitary–adrenal (HPA) axis. AVP, secreted
from parvocellular neurons of the paraventricular nucleus
(PVN) of the hypothalamus, stimulates, in synergy with
CRH, the release of pituitary adrenocorticotropic hormone
(ACTH) (Gillies et al. 1982, Antoni 1993, Aguilera et al. 1994).
The effect of AVP on pituitary corticotrope cells is mediated
through the activation of the vasopressin 1b receptor (AVPR1B;
Aguilera et al. 1994).
AVP levels and secretion, as well asAVPmRNA expression
within the parvocellular PVN, increase in response to
repeated exposure to stressors such as restraint (de Goeij
et al. 1991, Ma et al. 1997) immobilization (Bartanusz et al.
1993, Makino et al. 1995) and foot shock (Bartanusz et al.
1993, Sawchenko et al. 1993, Makino et al. 1995) or during
the chronic stress of adjuvant arthritis (Chowdrey et al. 1995).
Moreover, following chronic stress, an increased number of
AVPR1B in the pituitary has been observed (Aguilera et al.
1994, Rabadan-Diehl et al. 1995). These data suggest thatAVP plays an important role in regulating HPA axis activity
under conditions of repeated or chronic stress.
In rodents, exposure to chronic stress alters the sensitivity of
the HPA axis to further stressful stimuli. Rats exposed to
repeated restraint show habituation of the pituitary–adrenal axis
to subsequent acute restraint (Natelson et al. 1988, Chen &
Herbert 1995, Ma et al. 1997, Ma & Lightman 1998, Stamp &
Herbert 1999, Girotti et al. 2006). On the other hand, exposure
to repeated restraint induces sensitizationof theACTHresponse
to a novel stress (Hashimoto et al. 1988,Hauger et al. 1990). This
has led to the current concept of habituation to the same
(homotypic) stressor and sensitization to novel (heterotypic)
stressors. There is evidence to suggest that AVP could be
involved in both HPA axis habituation (Scaccianoce et al. 1991)
and sensitization (Hashimoto et al. 1988).
In this study, we used a recently identified AVPR1B
antagonist (Org), which is able to bind to the human
recombinant AVPR1B with high affinity and O1000-fold
selectivity over other members of the AVP receptor subfamily
and a broad range (O60) of other receptors, ion channels,
transporters, and enzymes (Presland et al. 2007, Craighead
et al. 2008). We have recently shown that this AVPR1BDOI: 10.1677/JOE-08-0425
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exogenous AVP in rats (Spiga et al. 2008). Furthermore, in the
same report, we have shown that the same compound is able
to reduce ACTH release induced by acute exposure to stress.
Those data were consistent with the previous studies where
the AVPR1B antagonist SSR149415 was found effective on
stress-induced ACTH increase (Serradeil-Le et al. 2002,
Ramos et al. 2006).
We have therefore used the AVPR1B antagonist Org to
investigatewhether AVPR1B plays a role inmediating the effect
of repeated exposure to stress on the HPA axis response to both
homotypic and heterotypic stressors. In the present study, the
effects of chronic restraint (CR) on HPA axis responses to
re-exposure to stress (homotypic and heterotypic) and to the
administration ofAVPwere investigated.Moreover, the effect of
the AVPR1B antagonist on these effects was investigated.Materials and Methods
Subjects
All experiments were conducted on male Sprague–Dawley
rats (Harlan-Olac, Bicester, UK) weighing 250–300 g at the
time of surgery. Animals were group housed (four in each
cage) and allowed to acclimatize to the housing facility for a
minimum of 1 week prior to the start of experiments. Rats
were maintained under standard environmental conditions
(21G1 8C) under a 14 h light: 10 h darkness schedule (lights
on at 0515 h) and food and water were provided ad libitum
throughout the experiment. All animal procedures were
approved by the University of Bristol Ethical Review Group
and were conducted in accordance with Home Office
guidelines and the UK Animals (Scientific Procedures) Act,
1986. All possible efforts were made to minimize the number
of animals used and their suffering.Surgery and blood sampling
Animals were anesthetized with a combination of Hypnorm
(0.32 mg/kg fentanyl citrate and 10 mg/kg fluanisone, i.m.;
Janssen Pharmaceuticals, Oxford, UK) and diazepam
(2.6 mg/kg i.p.; Phoenix Pharmaceuticals, Gloucester, UK).
The right jugular vein was exposed and a silastic-tipped (i.d.
0.50 mm, o.d. 0.93 mm, Merck) polythene cannula (Portex,
Hythe, UK) was inserted into the vessel until it lay close to the
entrance of the right atrium. The cannula was pre-filled with
pyrogen-free heparinized (10 IU/ml) isotonic saline. During
the same surgery, an s.c. cannula, for drug administration, was
inserted under the skin between the shoulder blades. The free
ends of both cannulae were exteriorized through a scalp
incision and then tunneled through a protective spring that
was anchored to the parietal bones using two stainless steel
screws and self-curing dental acrylic. Following recovery,
animals were housed in individual cages in a sound-proof
room. The end of the protective spring was attached to a
mechanical swivel that rotated 3608 in a horizontal plane andJournal of Endocrinology (2009) 200, 285–2911808 through a vertical plane allowing the rats to maximize
freedom of movement. The cannulae were flushed daily with
the heparinized saline to maintain patency. Blood samples
(0.2 ml) were collected by hand through cannula inserted in
the jugular vein and stored in ice-cold eppendorf tubes
containing 10 ml EDTA (0.5 M; pH 7.4) and 10 ml Trasylol
(Aprotinin, 500 000 KIU/ml, Roche). Plasma was separated
by centrifugation and then stored atK80 8C until processed
for corticosterone and ACTH measurements.
Drug treatments
The AVPR1B antagonist (Org, provided by Schering-Plough
Corporation, Newhouse, UK, Patent no. WO/2006/095014
A1) was administered through the s.c. cannula in a 0.9% saline
solution with 5% mulgofen, a detergent that improves
solubility (GAF Ltd, Manchester, UK), and administered at
2 ml/kg. Vehicle controls were injected with 0.9% saline
solution with 5% mulgofen. AVP (Sigma) was administered
via the jugular vein cannula at 100 ng (w400 ng/kg)
dissolved in 0.1 ml 0.9% saline. In all the experiments, the
dose of Org used was 30 mg/kg. We have recently shown that
this dose antagonized AVP-induced ACTH release. Both s.c.
and i.v. injections were followed by an injection of 0.2 ml
heparin–saline to flush out the cannula and ensure that the
entire volume of drug had been received by the animal.
Experimental procedures
Rats were either left undisturbed in their home cage as controls
(HCC) or exposed toCR(exp. 1–4) or single restraint (SR, exp.
4). SR or CR (11 days) was performed in the room where the
rats were housed and blood samples were collected. Restraint
consisted of placing the rats for 1 h in cylindrical Perspex
restrainers (diameter of 55 mm) provided with air holes to
prevent overheating. The length of the restrainer was adjusted
for the lengthof the rat in order to limitmovement.On the sixth
day of restraint, rats were implanted with both jugular and s.c.
cannula as previously described. Experiments were performed
6 days after surgery, 24 h after the last restraint between0900 and
1300 h, as following.
Rats from all groups were injected with Org (30 mg/kg,
s.c.) or vehicle (5% mulgofen, 2 ml/kg, s.c.), 30 min prior to
acute administration of AVP (exp. 1), exposure to acute
restraint (exp. 2), administration of lipopolysaccharide (LPS;
100 ml; Escherichia coli; 055: B5; 250 mg/ml i.v.; Sigma, exp.
3), or exposure to white noise (96 dB, 10 min; exp. 4). We
have recently shown that this compound, injected 30 min
prior to AVP, is able to reduce both ACTH and
corticosterone response to AVP (Spiga et al. 2008). Thus,
this time point for Org administration in relation to both
stress and AVP was used in the present study. Blood samples
were collected by hand as described above. At the end of the
sampling period, rats were overdosed with 0.5 ml Euthatal
(200 mg/ml sodium pentobarbital; Merial, Harlow, UK).
Blood samples were processed for ACTH and corticosterone
measurements as described below.www.endocrinology-journals.org
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ACTH and corticosterone levels were measured by IRMA
and RIA respectively. For ACTH measurement, 80 ml plasma
were diluted in 120 ml saline. Intra- and inter-assay
coefficients of variation of the ACTH assay were 2.84 and
6.41% respectively. For corticosterone measurements, 5 ml of
each plasma sample was diluted in 500 ml of a citrate buffer
and processed in triplicate as previously described (Spiga et al.
2007). Intra- and inter-assay coefficients of variation of the
corticosterone assay were 16.65 and 13.30% respectively.Figure 1 Effect of chronic restraint (CR) on (A) ACTH and
(B) corticosterone responses to exogenous vasopressin (AVP) and
modulation by a AVPR1B antagonist. Twenty-four hours after the
last restraint, control rats (HCC) or CR rats (1 h/day for 11 days)
received an acute injection of Org (30 mg/kg, s.c.) or vehicle (5%
mulgofen in saline, 0.2 ml/kg, s.c.) 30 min prior to i.v. adminis-
tration of AVP (100 ng/0.1 ml, i.v.). Black arrows indicate Org or
vehicle injection, grey arrows indicate AVP injection. Data points
represent mean (nZ6–10)GS.E.M. *P!0.05: effect of Org in HCC
and CR rats.Statistical analysis
All statistical analyses were performed using SPSS 11.5 for
Windows (SPSS Inc, Chicago, IL, USA). Data are expressed
as meanGS.E.M.
The effect of restraint exposure (CR versus HCC or SR
versus HCC) and Org treatment on the time course of ACTH
and corticosterone secretion following acute challenge (AVP
administration in exp. 1 or acute stress in exp. 2–4, time effect)
was analyzed by repeated-measures ANOVA. Significant
interactions between time and other factors (restraint and
Org) were further analyzed by Fisher’s least significant
difference post hoc test. For clarity, results of HCC group
from exp. 4 are represented in two different figures (see
results). Statistical significance was set at P%0.05.Results
Experiment 1. Effect of the AVPR1B antagonist Org on ACTH
and corticosterone secretion induced by exogenous AVP
As expected, acute administration of AVP increased ACTH
secretion (Fig. 1A; time effect: F (6,186)Z215.324;
P!0.0001) and this effect was reduced by pretreatment
with the AVPR1B antagonist Org in both HCC and CR rats
(time!Org effect: F (6,186)Z35.054; P!0.0001). There
was no significant effect of CR on the ACTH response to
AVP or on the effect of Org.
AVP also increased corticosterone secretion (Fig. 1B; time
effect: F (6,186)Z68.867; P!0.0001), and, as for ACTH,
this effect was reduced by the AVPR1B antagonist Org
(time!Org: F (6,186)Z8.633; P!0.0001). There was no
significant effect of CR on the corticosterone response to
AVP or on the effect of Org.Figure 2 Effect of CR on (A) ACTH and (B) corticosterone responses
to acute re-exposure to restraint and modulation by a AVPR1B
antagonist. Twenty-four hours after the last restraint, home cage
control rats (HCC) or CR rats (1 h/day for 11 days) received an acute
injection of Org (30 mg/kg, s.c.) or vehicle (5% mulgofen in saline,
0.2 ml/kg, s.c.) 30 min prior to a challenge with a further restraint
session (1 h). Black arrows indicate Org or vehicle injection,
shaded bars indicate restraint stress. Data points represent mean
(nZ7–11)GS.E.M. #P!0.05: effect of CR in vehicle or Org treated
rats. *P!0.05: effect of Org in HCC and CR rats.Experiment 2. Effect of the AVPR1B antagonist Org on ACTH
and corticosterone secretion induced by acute restraint
Exposure to acute restraint induced a significant increase on
ACTH secretion (Fig. 2A; time effect: F (8,256)Z56.552;
P!0.0001). Moreover, there was a significant effect of CR on
ACTH secretion induced by exposure to acute restraint
(time!CReffect: F (8,256)Z38.883; P!0.0001), indicating
that exposure to CR induced habituation of the ACTHwww.endocrinology-journals.orgresponse. In fact, all groups of CR rats, whether pretreated
with vehicle or the AVPR1B antagonist Org, showed a
significantly reduced ACTH response to acute re-exposure.
There was however a significant effect of Org (time!Org
effect: F (8,256)Z8.023; P!0.0001). Org reduced the
ACTH response to restraint in HCC, compared with vehicle,
whereas ACTH response in CR rats treated with Org was
unchanged, when compared with HCC rats.
A similar habituation response was seen for corticosterone.
There was a significant effect of acute restraint on corti-
costerone secretion (Fig. 2B; time effect: F (8,256)Z48.426;Journal of Endocrinology (2009) 200, 285–291
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corticosterone secretory response to further acute restraint
(time!CR effect: F (8,256)Z27.375; P!0.0001). CR rats
pretreated with either vehicle or Org had a reduced
corticosterone response to acute re-exposure to restraint
stress. No effect of Org on corticosterone secretion induced
by acute restraint was observed in HCC rats, nor did Org
affect the corticosterone response in CR rats.Figure 4 Effect of CR on (A) ACTH and (B) corticosterone responses
to acute exposure to noise and modulation by a AVPR1B antagonist.
Twenty-four hours after the last restraint, home cage control rats
(HCC) or CR rats (1 h/day for 11 days) received an acute injection of
Org (30 mg/kg, s.c.) or vehicle (5% mulgofen in saline, 0.2 ml/kg,
s.c.) 30 min prior to exposure to noise (96 dB, 10 min). Black arrows
indicate Org or vehicle injection, shaded bars indicate noise.
Data points represent mean (nZ9–12)GS.E.M. #P!0.05: effect of
CR in vehicle or Org treated rats. *P!0.05: effect of Org in HCC
and CR rats.Experiment 3. Effect of the AVPR1B antagonist Org on ACTH
and corticosterone secretion induced by acute LPS
LPS induced a significant increase in ACTH secretion
(Fig. 3A; time effect: F (9,216)Z83.215; P!0.0001),
which was not altered by prior exposure to CR. The
AVPR1B antagonist Org diminished the response to LPS
compared with rats injected with vehicle (time!Org effect:
F (9,216)Z13.915; P!0.0001) and this effect was significant
in both HCC and CR groups between 30 and 120 min after
LPS administration.
Corticosterone showed a similar pattern of response with
a marked increase following LPS (Fig. 3B; time effect:
F (6,216)Z173.502; P!0.0001), but no effect of CR on sub-
sequent LPS-induced corticosterone secretion was observed.
No effect of Org was observed in either HCC or CR rats.Experiment 4. Effect of the AVPR1B antagonist Org on ACTH
and corticosterone secretion induced by acute noise stress
Experiment 4.1. Chronic restraint Exposure to acute
noise induced a significant increase in ACTH secretion
(Fig. 4A; time effect: F (6,234)Z159.054; P!0.0001).
There was also a significant effect of CR on the ACTHFigure 3 Effect of CR on (A) ACTH and (B) corticosterone responses
to acute administration of lipopolysaccharide (LPS) and modulation
by a AVPR1B antagonist. Twenty-four hours after the last restraint,
home cage control rats (HCC) or CR rats (1 h/day for 11 days)
received an acute injection of Org (30 mg/kg, s.c.) or vehicle (5%
mulgofen in saline, 0.2 ml/kg, s.c.) 30 min prior to a challenge with
acute LPS (250 mg, i.v.). Black arrow indicates Org or vehicle
injection, grey arrows indicate LPS injection. Data points represent
mean (nZ7)GS.E.M. *P!0.05: effect of Org in HCC and CR rats.
Journal of Endocrinology (2009) 200, 285–291response to acute noise (time!CR effect: F (6,234)Z7.881;
PZ0.0019). In comparison with HCC rats, CR rats showed a
higher ACTH response to noise, an effect that was significant
within 5 min of the onset of noise (PZ0.0026). Therewas also
a significant effect of Org (time!Org effect: F (6,234)Z
5.179; PZ0.0132). Despite the lack of effect of Org observed
inHCC rats exposed to noise, CR rats pretreatedwithOrg had
a significantly reduced ACTH response to noise (P!0.05)
although no significant interaction between CR and Org
(time!CR!Org effect) was found.
Acute noise also increased corticosterone secretion
(Fig. 4B; time effect: F (6,234)Z191.61; P!0.0001), but
in contrast to ACTH, there was no significant effect of CR on
the subsequent corticosterone response to acute noise.
Although repeated measure analysis revealed a significant
effect of Org on corticosterone secretion induced by noise
(time!Org effect: F (6,234)Z4.340; P!0.003) post hoc
analysis showed no effect within the experimental groups at
any of the time points analyzed.
Experiment 4.2. Single restraint Consistent with the
results from exp. 4.1, acute noise induced a significant increase
in ACTH secretion (Fig. 5A; time effect: F (6,180)Z117.695;
P!0.0001). There was also a significant effect of single
exposure to restraint on ACTH secretion induced by exposure
to acute noise (time!SReffect:F (6,180)Z3.595;PZ0.031).
In comparisonwithHCCrats, SR rats showed a higherACTH
response to noise and an effect was significant within 15 min
from the onset of the noise (PZ0.0063). There was also a
significant effect ofOrg (time!Org effect:F (6,180)Z5.7209;
PZ0.0045). As described for exp. 4.1, although only SR rats
pretreated with Org had a significantly reduced ACTHwww.endocrinology-journals.org
Figure 5 Effect of a single exposure to restraint on (A) ACTH and (B)
corticosterone responses to acute exposure to noise and modulation
by a AVPR1B antagonist. Twenty-four hours after restraint, home
cage control rats (HCC) and rats exposed to restraint (SR) received
an acute injection of Org (30 mg/kg, s.c.) or vehicle (5% mulgofen
in saline, 0.2 ml/kg, s.c.) 30 min prior to exposure to noise (96 dB,
10 min). Black arrows indicate Org or vehicle injection, shaded
bars indicate noise. Data points represent mean (nZ7–8)GS.E.M.
#P!0.05: effect of SR in vehicle or Org treated rats. *P!0.05: effect
of Org in HCC and SR rats.
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between SR and Org (time!SR!Org effect) was found.
Acute noise also induced a significant increase on corticos-
terone secretion (Fig. 5B; time effect: F (6,180)Z122.485;
P!0.0001), but, as seen in exp. 4.1, there was no significant
effect of single exposure to restraint on corticosterone secretion
induced by acute noise. Although repeated measure analysis
revealed a significant effect of Org on corticosterone secretion
induced by noise (time!Org effect: F (6,180)Z2.623;
P!0.042), post hoc analysis showed no effect within the
experimental groups at any of the time points analyzed.Discussion
The plasticity of the HPA axis response to stress is of clear
survival value to animals that need to adapt to changing
physiological, pathological, and environmental conditions.
The mechanism underlying this plasticity is however unclear.
It is known that one aspect of HPA axis plasticity is its ability
to show modification in response to the history of previous
stressful experiences so that exposure to repeated stress leads
to changes in the HPA axis response to subsequent challenges.
The characteristics of the stressor, such as intensity (Natelson
et al. 1988, Pitman et al. 1990), frequency (De Souza &
Van Loon 1982, De Boer et al. 1990, Ma & Lightman 1998),
and nature (i.e. psychological versus physical; for review see
(Aguilera et al. 1994)) are important in the development of
both habituation and sensitization of the HPA axis response to
a further challenge with a stressor (see (Dallman 2007) for
review). We have used the paradigm of repeated acute
restraint, which has been shown to result in both habituation
of the HPA axis in response to a homotypic stressor (restraint)
and sensitization to heterotypic stressors.www.endocrinology-journals.orgUsing this model, we have been able to confirm that the
pituitary and adrenal responses to acute restraint were
suppressed in rats exposed to restraint for the previous
11 days. Several studies have investigated the neuronal sites
involved in HPA axis habituation. A decrease in Fos mRNA
or Fos protein expression was found within the PVN (Girotti
et al. 2006) and other brain areas related to the HPA axis, such
as medial and central nuclei of the amygdala and lateral
septum (Umemoto et al. 1994, Watanabe et al. 1994, Chen &
Herbert 1995, Stamp & Herbert 1999). We have previously
shown that in parallel with a progressive reduction of
corticosterone response to acute restraint, exposure to
repeated restraint also reduces CRF hnRNA expression
within the PVN, but increases the AVP mRNA response to
acute restraint (Ma et al. 1997, Ma & Lightman 1998). This
increase in mRNA is also associated with increased levels of
AVP in portal blood (Chowdrey et al. 1995). Taken together
with the data from several other groups, these data suggest that
AVP could be a good candidate as a modulator of the HPA
axis response during repeated or chronic stress. We have
therefore investigated the role of pituitary AVPR1B in
mediating HPA axis habituation and sensitization using the
selective AVPR1B antagonist Org. We have recently shown
that acute administration of the AVPR1B antagonist Org in
rat reduces the ACTH response to acute stress (Spiga et al.
2008) and those data are consistent with other reports where
the AVPR1B antagonist, SSR149415 was described to be
effective on reducing ACTH release induced by acute stress
(Serradeil-Le et al. 2002, Ramos et al. 2006). Those studies
showed that SSR149415 was effective at lower doses than the
dose of Org used in our studies. However, the effect of
SSR149415 on the activity of the HPA axis following
repeated exposure to stress has not been investigated.
Pretreatment with Org does result in a reduction of the
ACTH and corticosterone responses to exogenous AVP both
in HCC and CR animals, confirming the effectiveness of this
agent in antagonizing the pituitary corticotrope response to
AVP. Org also reduces the ACTH – but not the
corticosterone – response to acute restraint, confirming the
modulatory role of endogenous AVP in this acute stress
response (Spiga et al. 2008). The lack of effect of Org on
corticosterone secretion induced by stress could be due to the
fact that, even following Org treatment, ACTH levels are still
high enough to induce a normal corticosterone response to
stress. Moreover, a pituitary-independent modulation of
adrenal corticosterone secretion cannot be excluded, as
suggested by the evidence for modulation of adrenal
glucocorticoid secretion by the sympathetic innovation of
the adrenal gland (Engeland & Arnhold 2005).
AVPR1B blockade does not, however, alter the degree of
habituation of the pituitary–adrenal response to repeated
restraint, suggesting a different mechanism probably at a
central level. This hypothesis is supported by the evidence
that blockade of central mineralocorticoid receptors can
prevent habituation of the corticosterone response to repeated
restraint (Cole et al. 2000). Our data suggest that the effects ofJournal of Endocrinology (2009) 200, 285–291
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development of habituation to restraint.
Exposure to repeated restraint also sensitizes the HPA axis
response to a novel stressor, and we have investigated the effect
of CR on pituitary–adrenal responses to the heterotypic
stressors LPS and noise stress. Chronic stress had no effect on
the ACTH and corticosterone response to LPS. This may
relate to the potent immunological activation of the HPA axis
by LPS and is consistent with previous observations
(Fernandes et al. 2002). It is possible that the dose of LPS
used in this study induced maximum ACTH and corticos-
terone release. Previous reports described the sensitization of
both ACTH and corticosterone response to LPS 24 h after
exposure to acute stress; however, a much lower dose of LPS
was used in those studies ( Johnson et al. 2002a,b, Dallman
2007). Therefore, lower doses of LPS may be needed to
determine whether repeated restraint would induce sensi-
tization of ACTH and corticosterone response to LPS.
Chronic stress did however result in sensitization of the
pituitary response to the noise stressor with an increase in the
ACTH response 5 min after the onset of the stress. It was very
interesting to note that even a single episode of restraint was
enough to sensitize the ACTH response to noise applied 24 h
later, with an increased ACTH response 15 min after the
onset of the stress. There was however no effect of CR or SR
on the corticosterone response to acute noise. Similar
discrepancies between pituitary and adrenal responses to stress
have been previously described (Gagliano et al. 2008) and may
be related to the modulation of adrenal response to ACTH via
adrenal sympathetic innervation (Engeland & Arnhold 2005).
Org reduced the ACTH response to noise in CR rats,
despite its lack of effect during CR. In fact, regardless of
previous exposure to restraint, Org reduced the ACTH
responses to noise stress. We also found a similar effect of Org
on the corticosterone response to noise with a small but
significant reduction in corticosterone which paralleled the
reduced ACTH response.
With respect to the ACTH response to noise in rats
exposed to acute restraint, there was a significant effect of Org
on ACTH, which was independent of a history of previous
episodes of acute restraint. The effect of noise was stronger in
rats exposed to acute restraint compared with naı¨ve rats. We
also found a modest, but significant effect on the corticos-
terone response to noise.
The exaggerated ACTH response to noise in both CR and
SR rats was reduced by treatment with Org, supporting an
involvement of AVP on the HPA axis response to stress. These
data suggest that the vasopressinergic system is involved in
sensitization of the HPA response in this situation. The
mechanism of this could involve both increased release of portal
AVP (Chowdrey et al. 1995) and/or the described increase in
AVPR1B density in the anterior pituitary (Aguilera et al. 1994,
Rabadan-Diehl et al. 1995). Although chronic exposure to cold
stress does seem to increase pituitary sensitivity via increased
AVPR1B activity, this does not seem to be the explanation inJournal of Endocrinology (2009) 200, 285–291our current studies, as there is change neither in sensitivity to
exogenous AVP nor in their response to Org.
Our observation that Org reduced the exaggerated ACTH
response to noise found in rats treated with vehicle is
consistent with the work of Fred Tilders who showed that a
single exposure to stress could result in increases in median
eminence AVP lasting 11 days (Schmidt et al. 1996). The same
authors also showed that subsequent activation of the HPA
axis during this period resulted in an increased ACTH and
corticosterone response (Schmidt et al. 1995).
The long-lasting effect of a single exposure to stress on
ACTH has also been reported in others studies (Johnson et al.
2002a, Armario et al. 2004, O’Connor et al. 2004), and effects
on basal Crh mRNA levels in the PVN and increased stress-
induced FosmRNA in the PVNhave been described 24 h after
exposure to an acute inescapable shock (O’Connor et al. 2004).
Our data suggest that pituitary AVPR1B and portal AVP
could play an important role in the response to stress not only in
naı¨ve rats but also in the sensitized ACTH response to a
heterotypic stressor in chronically restrained animals. Since
stress-induced sensitization of pathways regulating theHPA axis
has been implicated in the pathogenesis of psychiatric disease, in
particular in depression (Pariante et al. 1995, Heim et al. 2008),
the use of a AVPR1B antagonist could represent an interesting
therapeutic avenue for the treatment of these mood disorders.Declaration of interest
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